it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. http://lm360.us/Makar-son-of-Frohling-from-Buenamadre?Trestgran=178 : bwire: the major problem at knh is structural and system failures .
-
.
.